Clinical Trial Update: Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

An extension is announced for a Phase 2 trial evaluating pomegranate extract on rising PSA levels after primary therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pomegranate Extract

Snippet

Sponsor: Roll International Corporation | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN